购物车
- 全部删除
- 您的购物车当前为空
LHF-535 是一种抗病毒剂,对 Lassa,Machupo,Junin,VSVg 病毒的 EC50分别为 <1 μM,<1 μM,<1 μM 和 1-10 μM
LHF-535 是一种抗病毒剂,对 Lassa,Machupo,Junin,VSVg 病毒的 EC50分别为 <1 μM,<1 μM,<1 μM 和 1-10 μM
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 283 | 现货 | |
2 mg | ¥ 395 | 现货 | |
5 mg | ¥ 663 | 现货 | |
10 mg | ¥ 958 | 现货 | |
25 mg | ¥ 1,780 | 现货 | |
50 mg | ¥ 2,860 | 现货 | |
100 mg | ¥ 4,230 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 728 | 现货 |
产品描述 | LHF-535 is an antiviral compound. It has EC50s of <1 μM, <1 μM, <1 μM, and 1-10 μM for Lassa, Machupo, Junin, and VSVg virus, respectively. |
体外活性 | LHF-535 is a small-molecule viral entry inhibitor that targets the arenavirus envelope glycoprotein (GP). LHF-535 inhibits Lassa GP-pseudotyped lentivirus (IC50: 0.1-0.3 nM). LHF-535 shows effective antiviral activity against a broad array of hemorrhagic fever arenaviruses [2]. |
体内活性 | An increase in survival is also observed when the first dose of LHF-535 (10 mg/kg) is delayed by 1, 2, or 3 days after infection. LHF-535 (3, 10 or 30 mg/kg; orally; daily; 14 days) protects mice from a lethal challenge with Tacaribe virus and dramatically reduces viral titers in plasma, spleen, and liver [2]. |
分子量 | 412.52 |
分子式 | C27H28N2O2 |
CAS No. | 1450929-77-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 96.67 mg/mL (234.34 mM), Sonication is recommended. H2O: < 0.1 mg/mL (insoluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.